Mengyue Li
Papers
2
Total Citations
37
H-Index
2
About
Dr. Mengyue Li is pioneering the next generation of biohybrid microrobots for precision medicine, with a focus on overcoming the formidable biological barriers that limit drug delivery to the brain. Her research sits at the intersection of micro/nanorobotics, targeted therapy, and intelligent control systems. In her highly cited 2024 work, Dr. Li introduced a cross-scale drug delivery system using diatom microrobots propelled by a magnetic continuum robot, achieving combined chemical and photodynamic therapy for glioblastoma. This breakthrough addresses the dual challenges of long-distance intravenous travel and the blood-brain barrier, demonstrating a viable path to treating one of the most aggressive brain cancers. Her 2025 study further advances the field by integrating deep learning for automatic control of these biohybrid microrobots, enabling real-time environmental detection and path planning for autonomous targeted delivery. With over 30 citations on her recent glioblastoma work alone, Dr. Li’s contributions are rapidly shaping the future of intelligent, bioinspired therapeutic systems, offering new hope for patients with previously intractable conditions.
Research Focus
Key Achievements
Top Papers
- 1
- 2